Treatment with modulators of plasma membrane NCX, such as KB-R794 and SEA 0400, increase contractile recovery after ischemia, reducing cytosolic accumulation of Ca2+ and mitochondrial influx of Na+ on reperfusion in hearts submitted to cardiac I/R injury [104,105,106]. The gene discussed is TLX2; the disease is ischemia.